Clinical trials
Phase 2 Kidney Failure, Chronic trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 2 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 3 |
| Eledon Pharmaceuticals | 2 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 2 |
| Bayer | 1 |
| Dr. Rachel Holden | 1 |
| Ionis Pharmaceuticals, Inc. | 1 |
| Merck Sharp & Dohme LLC | 1 |
| OPKO IP Holdings II, Inc. | 1 |
| Rockwell Medical Technologies, Inc. | 1 |
| Toronto Rehabilitation Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Failure, Chronic | 17 |
| Renal Insufficiency, Chronic | 5 |
| Renal Insufficiency | 2 |
| Constriction, Pathologic | 1 |
| Hyperparathyroidism | 1 |
| Hyperparathyroidism, Secondary | 1 |
| Kidney Diseases | 1 |
| Parathyroid Diseases | 1 |
| Peritoneal Fibrosis | 1 |
| Restless Legs Syndrome | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.